Morgan Stanley’s Theriva Biologics TOVX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q4
Sell
-20,200
Closed -$27.9K 8088
2024
Q3
$27.9K Buy
20,200
+20,199
+2,019,900% +$27.9K ﹤0.01% 6396
2024
Q2
$4 Hold
1
﹤0.01% 7815
2024
Q1
$7 Sell
1
-40
-98% -$280 ﹤0.01% 7782
2023
Q4
$444 Buy
+41
New +$444 ﹤0.01% 7292
2023
Q3
Hold
0
-$12 7578
2023
Q2
Hold
0
-$7 7598
2023
Q1
Sell
-27
Closed -$305 7681
2022
Q4
$305 Buy
27
+15
+125% +$169 ﹤0.01% 7605
2022
Q3
$0 Hold
12
﹤0.01% 7873
2022
Q2
$1K Buy
12
+1
+9% +$83 ﹤0.01% 7706
2022
Q1
$1K Sell
11
-73
-87% -$6.64K ﹤0.01% 7872
2021
Q4
$6K Hold
84
﹤0.01% 7611
2021
Q3
$10K Buy
84
+83
+8,300% +$9.88K ﹤0.01% 7332
2021
Q2
$0 Hold
1
﹤0.01% 7802
2021
Q1
$0 Hold
1
﹤0.01% 7564
2020
Q4
$0 Hold
1
﹤0.01% 7112
2020
Q3
$0 Hold
1
﹤0.01% 6826
2020
Q2
$0 Sell
1
-1
-50% ﹤0.01% 6722
2020
Q1
$0 Buy
2
+1
+100% ﹤0.01% 6706
2019
Q4
$0 Hold
1
﹤0.01% 6762
2019
Q3
$0 Hold
1
﹤0.01% 6758
2019
Q2
$0 Sell
1
-1
-50% ﹤0.01% 6748
2019
Q1
$0 Hold
2
﹤0.01% 6706
2018
Q4
$0 Hold
2
﹤0.01% 6736
2018
Q3
$1K Sell
2
-2
-50% -$1K ﹤0.01% 6652
2018
Q2
$9K Buy
4
+1
+33% +$2.25K ﹤0.01% 6333
2018
Q1
$7K Buy
3
+1
+50% +$2.33K ﹤0.01% 6342
2017
Q4
$10K Sell
2
-2
-50% -$10K ﹤0.01% 6219
2017
Q3
$35K Sell
4
-26
-87% -$228K ﹤0.01% 5882
2017
Q2
$151K Buy
30
+11
+58% +$55.4K ﹤0.01% 5469
2017
Q1
$106K Sell
19
-26
-58% -$145K ﹤0.01% 5578
2016
Q4
$300K Buy
45
+31
+221% +$207K ﹤0.01% 5186
2016
Q3
$215K Buy
14
+1
+8% +$15.4K ﹤0.01% 4984
2016
Q2
$197K Sell
13
-4
-24% -$60.6K ﹤0.01% 4945
2016
Q1
$349K Buy
17
+3
+21% +$61.6K ﹤0.01% 4640
2015
Q4
$279K Sell
14
-21
-60% -$419K ﹤0.01% 4903
2015
Q3
$701K Buy
35
+27
+338% +$541K ﹤0.01% 4381
2015
Q2
$194K Hold
8
﹤0.01% 5258
2015
Q1
$151K Buy
8
+4
+100% +$75.5K ﹤0.01% 5337
2014
Q4
$51K Hold
4
﹤0.01% 5814
2014
Q3
$57K Hold
4
﹤0.01% 5687
2014
Q2
$55K Sell
4
-35
-90% -$481K ﹤0.01% 5736
2014
Q1
$884K Buy
39
+36
+1,200% +$816K ﹤0.01% 4104
2013
Q4
$41K Sell
3
-2
-40% -$27.3K ﹤0.01% 5668
2013
Q3
$79K Hold
5
﹤0.01% 5140
2013
Q2
$81K Buy
+5
New +$81K ﹤0.01% 5121